Expert Ratings
Easily search Stocks, Mutual Funds, Articles and Videos
Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Headquartered in Hyderabad, Cohance Lifesciences is a global, innovation-driven CDMO platform specialising in high-value, end-to-end solutions across the full spectrum of a molecule’s lifecycle - from early-stage development to large-scale commercialisation - with a marquee Customer Base across Pharmaceuticals and Specialty Chemicals.
With a focus on agility, innovation and global scalability, Cohance Lifesciences is reshaping the landscape of pharmaceutical manufacturing and development. The company collaborates with its customers to enhance their molecules and products, enabling them to deliver innovative solutions to their patients and consumers.
Business area of the company
The company is a fully integrated global CDMO, partnering with leading innovators across the entire product lifecycle- from route scouting and early development to commercial manufacturing. With advanced capabilities in oligonucleotides, bioconjugation and complex small molecules, it addresses some of the most challenging chemistries in the industry.
Business verticals of the company
Achievements
Achieved B-rating 2024 disclosure both in Climate Change & Water Security.
Social Accountability SA8000.
Silver in Ecovadis Sustainability Assessment.
Pharmaceutical Supply Chain Initiative (PSCI) Supplier Partner- 2025.
British Safety Council’s International Safety Awards (ISA) 2025.
All facilities are certified with ISO 14001, ISO 45001.
Milestones
Comment